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Abstract
Sleep apnea and hypopnea syndrome (SAHS) is a disorder characterized by intermittent and repetitive obstruction 
of the upper airway provoking pharyngeal collapse. It is characterized clinically by a triad of daytime hypersomnia, 
snoring and pauses in breathing during sleep that are normally reported by the partner. Polysomnography is the cho-
sen method for diagnosing this pathology. Patients with this disorder tend to have the following dental and orofacial 
signs: a retrognathic jaw, a narrow palate, a wide neck, deviation of the nasal septum and relative macroglossia, among 
others. Dentists should be ready to evaluate the risk-benefit of certain dental treatment options for this public health 
problem. The treatment of this problem will depend on its severity, with one of the options being the Mandibular 
Advancement Device (MAD) that is used especially in the treatment of slight or moderate SAHS and in the treatment 
of snoring, with results that are occasionally very successful. The objective of this study is to carry out an up-to-date 
literature review of SAHS and to evaluate the role of the dentist when faced with this pathology.
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Introduction
Obstructive sleep apnea syndrome (SAHS) is a disorder 
that derives from the intermittent and repetitive occlusion 
of the upper airway during sleep. This occlusion is due 
to the inspiratory collapse of the walls of the pharynx, 
which determines the complete closure (apnea) or partial 
closure (hypopnea) of the airway. Apneas or hypopneas 
are of varying duration and have distinctive repercussions 
on cardiorespiratory homeostasis. Its repetition during 
sleep, sometimes several hundred times in one night, and 
day after day for years, ends up producing significant 
alterations in the central nervous system, in myocardial 
and cerebral circulation and in pulmonary and systemic 
circulation (1). 
From a clinical point of view, SAHS is characterized by 
the daytime triad hypersomnia, snoring and nocturnal 
apnea generally reported by the affected person’s part-
ner and are symptoms simultaneously present in nearly 
all patients. What is more, other neuropsychiatric and 
cardiorespiratory disorders frequently occur, that are 
secondary to the constant oxygen desaturations and the 
transitory and subconscious awakenings (“arousals”) that 
cause apneas (1).
SAHS is currently a public health problem of great im-
portance. Firstly, its main clinical manifestation, daytime 
hypersomnia, has an important impact on the family, work 
and society, including a deterioration in personal relation-
ships, job absenteeism, traffic accidents, etc. Secondly, 
its prevalence is estimated to be quite high (2-4). Studies 
recently carried out in our country have found varying 
figures, for the adult population, between 4% and 6 % in 
males and around 2 % in females (2,3). 
After the Spanish consensus of 2005 (3), a recommenda-
tion was made to use the term “Sleep Apnea Hypopnea 
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Syndrome” and its acronym “SAHS” given that this inclu-
des a specific reference to hypopneas, which are considered 
to be growing in importance in adults as well as children. 
This acronym omits the term “obstructive” and includes 
mixed and central apneas. Finally, this acronym coincides 
with the English definition of Sleep Apnea and Hypopnea 
Syndrome making it easier to use (1).
Objectives
- To carry out a bibliographical revision of Sleep Apnea-
Hypopnea Syndrome (SAHS).
- To describe the many dental and mouth problems that 
these patients have.
- To detail the treatments used for SAHS including the 
Mandibular Advancement Device (MAD).
- To determine the dentist’s role in the multidisciplinary 
treatment of this pathology.
Materials and Methods
 We have carried out a search of articles published during 
the last 10 years (1997-2007). The search was carried 
out in the following databases: Medline, PubMed, Base, 
web of sciences and Cochrane Library. For the search 
we used the words “sleep apnea”, “treatment of apnea”, 
“apnea and oral problems” and “degrees of mandibular 
advancement”. 
Results
We selected a total of 32 articles that were of many diffe-
rent types (clinical reviews, therapeutic procedures, case 
studies and controls). Those considered to be most impor-
tant have been summarized in the following table 1.
Physiopathology and systemic clinical manifesta-
tions
Snoring, an expression of the narrowing of the pharynx, is 
due to the vibration of the soft parts of the upper airway 
(the pharyngeal walls, the veil of the palate and the uvula). 
Furthermore, it is the most common symptom reported by 
patients with SAHS or by their partners on the patient’s 
behalf  (1,3). 
The main daytime manifestations are xerostomia, gas-
troesophageal reflux, impotence, irritability, depression, 
decreased libido, non-restorative sleep, concentration 
difficulties and headaches. Whilst nocturnal manifesta-
tions include diaphoresis, xerostomia, salivation, altered 
sleep-patterns, awareness of  apnea and sensation of 
suffocation or panting (3).
SAHS in these patients is frequently associated with 
neuropsychiatric and cardiorespiratory disorders (arte-
rial hypertension, cardiac insufficiency, bradycardia and 
nocturnal arrhythmias, dilated myocardiopathy, pulmo-
nary hypertension and ischemia in severe SAHS.) In these 
cases it is advisable to include an echocardiography in the 
clinical evaluation of this type of patient.
It is common to find these patients to be obese and this 
disorder is linked to the habit of  alcohol and tobacco 
consumption (3). 
Orofacial manifestations
The most common mouth and facial characteristics found 
include retrognathic jaw, a narrow palate, a wide neck, a 
deviated nasal septum and relative macroglossia (15-17).
Dental manifestations
It is very important to evaluate whether the patient is fo-
llowing a specific treatment for SAHS. A medical history is 
essential for evaluating the pressure that dental treatment 
generates for the patient. In non-diagnosed patients or 
those not treated for SAHS, arterial hypertension can be 
difficult to control, in fact some researchers have repor-
ted the worsening of asthma and epilepsy (16). It is very 
important to evaluate the use of vasoconstrictors in local 
anesthesia given to patients that might not be properly 
controlled. Tooth decay frequently occurs in these patients 
due to the medication that produces xerostomia. If  a pa-
tient requests dental treatment together with intravenous 
sedation, the dentist should know that a subgroup of the 
SAHS population suffers from airway obstruction after 
the administration of sedation. The dentist could be the 
first to recognize SAHS due to the repetition of apneic 
episodes during sedation. What is more, patients with 
SAHS might have associated gastroesophageal reflux 
disease (GERD), that increases the risk for the patient of 
experiencing accidental aspiration and subsequent lung 
inflammation. What is more, the discomfort due to GERD 
can be similar to chest pain during a dental appointment. 
When a patient with heart disease associated with SAHS, 
has a complaint about chest pain this is an obvious source 
of tension in the appointment (17).
Diagnosis 
The polysomnography is the most precise diagnostic me-
thod, although it is also the most laborious, complex and 
expensive, given that it requires the constant presence of 
specialized personnel for supervising and attending to the 
study throughout the whole night (15). Furthermore, this 
instrument is frequently badly-tolerated by patients, given 
the discomfort involved and the hospital setting in which 
it is carried out. On the other hand, the nocturnal cardio-
respiratory polygraphy, that can be used in the home, is a 
much simpler method, that does not require monitoring 
and is quite well-accepted by the patient. Its specificity in 
the identification of SAHS is high and its sensitivity is also 
good. Therefore, in recent years it has been promoted as 
an alternative to conventional polysomnography (16). 
Treatment
SAHS treatment is multifactorial and should encompass 
several aspects, which are not necessarily mutually exclu-
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Authors Year Type of study conclusions
Clark GT, Sohn JW, 
Hong CN. (5)
2000
Prospective study of 65 patients with a mandibular 
device.
There are complications due to the 
mandibular advancement device that we 
should evaluate as dentists.
Prinsell JR. (6)
2002
The author presents a retrospective review of 
20 patients who were treated surgically with 
maxillomandibular advancement (MMA) and who 
were diagnosed pre- and post-operatively using 
polysomnography.
MMA is an extremely appropriate and 
potentially definitive type of surgery that 
can significantly reduce SAHS health 
problems and provide financial savings 
for the healthcare system.
 Petit FX, Pépin JL, 
Bettega G, Sadek H, 
Raphaël B, Lévy P. (7)
2002
Prospective study of contraindications of 
mandibular advancement treatment in 100 patients.
 34 % of patients had TMD and dental 
problems. It is necessary to adequately 
evaluate these problems when a treatment 
is applied.
 Robertson C, 
Herbison P, Harkness 
M. (8)
2003
To determine occlusal changes in 100 patients who 
suffer after wearing the mandibular advancement 
device for SAHS.
Although the replies given by the subjects 
were very varied, the variation of the 
vertical dimension and “over biting” 
were evident 6 months after wearing the 
apparatus.
De Oliveira Almeida 
MA, de Britto Teixeira 
AO, Vieira LS, 
Quintão CC. (9)
2006
Bibliographical review. Treatment with mandibular advancement 
devices should be the treatment of choice 
for slight-moderate SAHS.
Bucca C, Cicolin A, 
Brussino L, Arienti A, 
Graziano A, Erovigni 
F et al. (10)
2006
Prospective study in 48 patients for evaluating 
whether there is a relationship between edentulism 
and the appearance of apnea.
Edentulism favors the appearance of 
sleep apnea. It could be due to the 
decrease in the retropharyngeal space.
Ziliotto KN, dos 
Santos MF, Monteiro 
VG, Pradella-Hallinan 
M, Moreira GA, 
Pereira LD   et al. (11)
2006
Study of cases and controls for relating  SAHS and 
auditory treatment.
Based on the results of this study, it could 
be concluded that there is a relationship 
between SAHS and auditory problems. 
Vidal S, Ferrer M, 
Masuet C, Somoza 
M, Martinez JI, 
Monasterio C. (12)
2007
 31 patients with SAHS were included in the 
study who were diagnosed using the conventional 
polysomnography and compared to 31 healthy 
individuals. The objective was to find out the values 
of the Spanish version of the FOSQ (questionnaire) 
and its benefit for evaluating the impact of 
hypersomnolence in people with suspicion of SAHS.
With this study it has been seen that 
the Spanish version of FOSQ is a good 
instrument for evaluating the impact 
of drowsiness on the daily activities of 
people with suspicion of  SAHS.
 Arias MA, Garcia-Rio 
F, Alonso-Fernandez 
A, Sanchez AM. (13)
2007
Bibliographical review. The presence of respiratory disorders 
during sleep in patients with heart 
failure is very frequent. In many of these 
patients, these disorders could favor the 
progression of the disease, and even have  
a causal role.
Masa Jiménez JF, 
Barbé Illa F, Capote 
Gil F, Chiner Vives 
E, Díaz de Atauri J, 
Durán Cantolla J et 
al. (4)
2007
A descriptive, observational and transversal study 
has been carried out. Contact was made with the 
public and private centers included in the catalogue 
of healthcare institutions of the Ministry of Health 
of 2005. Those that habitually evaluated patients 
with  SAHS were included.
The person responsible for each center completed a 
questionnaire about the availability of resources and 
delays in diagnosis.
It has been seen that there is a notable 
deficiency in resources leading to 
unacceptable waiting lists. Although 
the situation of diagnosing SAHS 
has changed favorably with respect 
to previous studies, it could still be 
improved. It is essential for health 
authorities to dedicate more resources to 
this public health problem.
Johal A, Patel SI, 
Battagel JM.(14)
2007
Study of cases and controls. The objective was 
to establish whether there were pharyngeal and 
craniofacial anatomical differences in 99 patients 
diagnosed with SAHS compared to the healthy 
control group.
There are structural and anatomical 
differences in patients with SAHS 
diagnosed as an intermaxillary space who 
have a narrower nasopharyngeal airway.
Table 1. Summary of the most important articles.
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sive (1). It is important for treatment to be approached 
using a multidisciplinary team.
1º. General measures
Obesity, nearly always present, should be treated with 
great energy, although it is true that in the long term, 
significant success is rarely achieved. Good sleep hygiene 
should be attempted, looking to achieve regularity in 
habits and timetables, and suppression, at least after a 
certain time in the afternoon, of alcohol and hypnotics 
or sedatives (18). 
2º. Sahs treatment with positive continuous upper airway 
pressure (cpap)
The treatment of choice for SAHS is CPAP. This is ca-
rried out at night using a nasal mask.  A specific level of 
pressure is applied in the upper airway (UA), preventing 
its collapse. The phenomenon produces a mechanical wi-
dening in the area of the UA. It has very few after effects 
and its treatment is efficient for obstructive, mixed and 
sometimes also central apneas. It is necessary for a sleep 
specialist to conduct patient follow-ups (1).
3º. Pharmacological treatment
Medroxyprogesterone acetate, almitrine, protriptyline 
and theophylline are some of the pharmaceuticals tested 
until now for the treatment of SAHS, although they are 
not very efficient. They might be recommended in certain 
specific cases (5) when CPAP does not work.
4º. Intraoral devices
The utilization of  intraoral apparatus (fig. 1) in the 
treatment of obstructive problems of the upper airway 
(UA) is not a new concept. The first publications about 
intraoral apparatus related to SAHS appeared in the 
1980’s in an attempt to look for therapeutic alternatives 
to surgical procedures and CPAP (19). 
Although there are more than 50 reported types of efficient 
apparatus for treating snoring on the market, mandibular 
advancement devices (MAD) in their two versions (fixed 
advancement and adjustable advancement), are really 
efficient for managing obstructive problems of the UA.
MAD’s carry out an anterior and inferior movement of 
the jaw generating anatomical variations in the UA that 
enable an increase in the pharyngeal area. This movement 
stabilizes and fixes the jaw and the hyoid bone, preventing 
the posterorotation of these structures during the decubi-
tus preventing blockage of the airway (20,21).
Although its main effect appears in the velopharyngeal area, 
they have repercussions for all the pharyngeal segments. 
There is initially an increase in rigidity and a swelling of 
the space between the anterior and posterior pharyngeal 
pillars. It has also been confirmed with axial magnetic re-
sonance imaging how a significant reduction in the width 
of the pharyngeal lateral walls can be produced that is even 
greater than the anteroposterior luminal increase. The soft 
palate is displaced ventrally and this increases the caliber 
of the lateral walls of the velopharyngeal area which are 
both factors that drastically reduce snoring (22).
MADs generate changes in local pharyngeal pressure that 
contributes to normalizing the physiological properties 
of  the UA (23). The altered anatomical relationship (ro-
tation and mandibular advancement) induce an increase 
in neurosensorial stimulation that increases the motor 
muscular tone and reduces the collapsibility of  the VAS. 
In the same way there is an increase in the action vector of 
the pharyngeal dilating muscles that, on being displaced 
centrally, increase in length and improve their contracti-
lity (20-21). MAD’s carry out a similar function to what 
happens during conscious sedation and in cardiopulmo-
nary resuscitation procedures, where, after ensuring and 
preserving the permeability of  the UA freeing it of  any 
type of  strange object, an anterior traction and inferior 
mandibular procedure is carried out (22,23).
Functional mandibular advancement induces changes in 
the position of  the hyoid bone towards a more forward 
position. It creates a new position of  balance of  the su-
prahyoid musculature, that favors an increase in volume 
and permeability of  the upper airway (24). Although the 
response is not the same in all patients, some authors 
admit that there is a dosis-dependent effect, given that as 
the grade of  mandibular advancement is increased there 
is an improvement in the patient’s clinical situation. 
In spite of  the considerable variability that we find bet-
ween the many MADs (25-28), there are enough propo-
nents in the scientific literature who have demonstrated 
its efficiency. All of  these published studies document the 
validity of  the method polysomnographically, although 
initially the design of  the apparatus does not seem to be 
related to its effectiveness (28). There are also patients 
for whom good results are not achieved: those with 
severe SAHS, given that although there is evidence and 
positive data for this group, the success rate is lower 
than in slight and moderate cases (29). These severe 
cases include patients with deficient protrusive (scarce 
mandibular advancement), great “over biting”, cases 
with dental and/or periodontal problems and patients 
with temporomandibular disorders.
Fig. 1. Mandibular advancement device (MAD) Snor-
ban®.
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The MAD is very efficient in the treatment of  snoring 
(elimination of  this in 50% of  cases) achieving a signi-
ficant reduction in 90%-100% of  patients, as well as an 
improvement in the patient’s sleep quality (19). 
General dentists could collaborate in SAHS therapy, 
using mandibular repositioners but they should be aware 
of  the potential occlusion shift that could result from the 
therapy. The researchers have reported occlusion shifts 
in patients who use mandibular advancement devices, 
with the appearance of  signs such as the development 
of  posterior open bite, inclination of  the incisors, an-
terior open bite and problems in temporomandibular 
articulation (17). 
5ª. Surgical treatment
As already indicated, some structural and anatomical 
anomalies of the upper airway require surgical treatment. 
Gastroplasty is recommended for the treatment of SAHS 
together with morbid obesity when CPAP is not efficient 
and there is considerable comorbidity (30).
Surgical treatment is controversial when SAHS is not rela-
ted to specific anomalies of the upper airway (1). Its results 
are not easy to predict before intervention and its use in 
the medium and short term is not very clear. Many types 
of technique are used. Tracheostomy is the most efficient 
surgical procedure, although the psychosocial consequen-
ces it causes have meant that it is specifically recommended 
only in serious cases in which other therapeutic options 
have failed. Surgical mandibular advancement, is another 
option in these cases (7). However, partial palate resection 
(PPR) and uvulopalatopharyngoplasty (UPPP) (31) are 
currently the surgical techniques most commonly used 
due to their relative simplicity (32). 
Conclusions
- The dentists or odontologists are sometimes the first 
professionals to suspect SAHS.
- The diagnostic method of choice for this pathology is 
polysomnography.
- A good early diagnosis permits the choice of a treatment 
that prevents future complications.
- There are more and more tests showing that mandibular 
advancement devices (MAD) improve subjective somno-
lence rates and breathing disorders during sleep, especially 
in cases of slight/moderate SAHS.
- It is necessary to be in touch with other healthcare profes-
sionals, in order to offer good multidisciplinary treatment 
in which the dentist has an important role.
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